Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.860
-0.020 (-0.41%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Intensity Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Intensity Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $19.33. The average 1-year stock price forecast is 297.74% higher than the current stock price, while the lowest is $7.00 (+44.03%) and the highest is $32 (+558.44%).
Price Target: $19.33 (+297.74%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Intensity Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 6 | 6 | 5 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 6 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +44.03% | Aug 18, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $30 → $15 | Buy | Reiterates | $30 → $15 | +208.64% | Aug 11, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Upgrades $38 → $20 | Buy | Upgrades | $38 → $20 | +311.52% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.36
from -8.56
EPS Next Year
-1.99
from -3.36
EPS and Forward PE are based on non-GAAP adjusted numbers.